| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
IRIDEX Corporation (NASDAQ: IRIX)
IRIX Technical Analysis
5
| As on 9th Jun 2023 IRIX SHARE Price closed @ 1.98 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.54 & Strong Sell for SHORT-TERM with Stoploss of 5.26 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IRIXSHARE Price
| Open | 1.98 | Change | Price | % |
| High | 2.10 | 1 Day | -0.05 | -2.46 |
| Low | 1.98 | 1 Week | -0.17 | -7.91 |
| Close | 1.98 | 1 Month | -0.30 | -13.16 |
| Volume | 6509 | 1 Year | -3.64 | -64.77 |
| 52 Week High 6.42 | 52 Week Low 2.00 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| IRIX Daily Charts |
IRIX Intraday Charts |
Whats New @ Bazaartrend |
IRIX Free Analysis |
|
|
IRIX Important Levels Intraday
| RESISTANCE | 2.21 |
| RESISTANCE | 2.14 |
| RESISTANCE | 2.09 |
| RESISTANCE | 2.05 |
| SUPPORT | 1.91 |
| SUPPORT | 1.87 |
| SUPPORT | 1.82 |
| SUPPORT | 1.75 |
IRIX Forecast April 2024
| 4th UP Forecast | 5.39 |
| 3rd UP Forecast | 4.3 |
| 2nd UP Forecast | 3.62 |
| 1st UP Forecast | 2.94 |
| 1st DOWN Forecast | 1.02 |
| 2nd DOWN Forecast | 0.34 |
| 3rd DOWN Forecast | -0.34 |
| 4th DOWN Forecast | -1.43 |
IRIX Weekly Forecast
| 4th UP Forecast | 2.96 |
| 3rd UP Forecast | 2.65 |
| 2nd UP Forecast | 2.45 |
| 1st UP Forecast | 2.26 |
| 1st DOWN Forecast | 1.70 |
| 2nd DOWN Forecast | 1.51 |
| 3rd DOWN Forecast | 1.31 |
| 4th DOWN Forecast | 1.00 |
IRIX Forecast2024
| 4th UP Forecast | 10.69 |
| 3rd UP Forecast | 7.9 |
| 2nd UP Forecast | 6.17 |
| 1st UP Forecast | 4.44 |
| 1st DOWN Forecast | -0.48 |
| 2nd DOWN Forecast | -2.21 |
| 3rd DOWN Forecast | -3.94 |
| 4th DOWN Forecast | -6.73 |
IRIDEX Corporation ( NASDAQ USA Symbol : IRIX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IRIX Business Profile
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California. Address: 1212 Terra Bella Avenue, Mountain View, CA, United States, 94043
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service